Evidence map›Paper›PMID 34361714›Full record

ArticleMolecules (Basel, Switzerland)2021

Inhibitory Activity and Mechanism Investigation of Hypericin as a Novel

Qi Dong, Na Hu, Huilan Yue, Honglun Wang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Computational screening for novelFrontiers in nutrition · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Future medicinal chemistry · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Retinal Toxicity Induced by Chemical Agents.International journal of molecular sciences · 2022
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qi DongCAS Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Xining 810008, China.ORCID 0000-0002-6192-1597
Na HuCAS Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Xining 810008, China.
Huilan YueCAS Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Xining 810008, China.
Honglun WangCAS Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Xining 810008, China.
Qinghai Tibetan Hospital · CN

Funding

Chinese Academy of Sciences "Light of West China" Program 2020Innovation Platform for the Development and Construction of Special Project of Qinghai Province 2020-0407-NCC-0001Innovation Platform for the Development and Construction of Special Project of Qinghai Province 2021-ZJ-T05National Natural Science Foundation of China 31800297National Natural Science Foundation of China 31870333Qinghai Provincial Science Foundation 2019-ZJ-7100Qinghai Provincial Science Foundation 2020-SF-A2
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-GlucosidasesAnthracenesBinding SitesFungal ProteinsGlycoside Hydrolase InhibitorsHumansHydrogen BondingHydrophobic and Hydrophilic InteractionsHypoglycemic AgentsKineticsMolecular Docking SimulationNitrophenylgalactosidesPeryleneProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-Strand4-nitrophenylgalactosidealpha-GlucosidasesAnthracenesFungal ProteinsGlycoside Hydrolase InhibitorshypericinHypoglycemic AgentsNitrophenylgalactosidesPerylenehypericinmechanismα-glucosidase inhibitor

Identifiers

PMID34361714
PMCPMC8348433
OpenAlexW3191605455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.